Stay updated on Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.3.3 is now displayed and the HHS Vulnerability Disclosure footer link was removed; these are cosmetic changes that do not affect study data or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:22:24.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    New revision entry v3.3.2 added. Revision v3.2.0 removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:20:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding lapse and operating status. The core trial content and links on the page remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-17T18:37:55.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The new version shows updates to Study Status and Eligibility, along with related changes in Oversight and Document sections, reflecting the trial's current state.
    Difference
    0.1%
    Check dated 2025-11-03T13:16:27.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Adds a new date (2025-10-09) and a new label/heading “19 2025-10-07 Study Status Oversight,” while removing the previous date (2025-04-22). This updates the page's temporal context and introduces a study status designation.
    Difference
    1%
    Check dated 2025-10-13T05:28:25.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    The page updates to v3.2.0 with a prominent government-operating-status notice; the prior v3.1.0 reference was removed.
    Difference
    12%
    Check dated 2025-10-06T04:13:31.000Z thumbnail image

Stay in the know with updates to Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.